Zynex (ZYXI)
(Delayed Data from NSDQ)
$12.65 USD
+0.10 (0.80%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $12.67 +0.02 (0.16%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for Zynex Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 184 | 158 | 130 | 80 | 45 |
Cost Of Goods | 38 | 32 | 27 | 17 | 9 |
Gross Profit | 146 | 126 | 103 | 63 | 37 |
Selling & Adminstrative & Depr. & Amort Expenses | 135 | 103 | 81 | 52 | 26 |
Income After Depreciation & Amortization | 11 | 23 | 22 | 10 | 11 |
Non-Operating Income | 3 | 0 | 0 | 0 | 1 |
Interest Expense | 1 | 0 | 0 | 0 | 0 |
Pretax Income | 13 | 22 | 22 | 10 | 12 |
Income Taxes | 3 | 5 | 5 | 1 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 10 | 17 | 17 | 9 | 9 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 10 | 17 | 17 | 9 | 9 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 15 | 26 | 25 | 12 | 12 |
Depreciation & Amortization (Cash Flow) | 4 | 3 | 2 | 2 | 1 |
Income After Depreciation & Amortization | 11 | 23 | 22 | 10 | 11 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 36.14 | 39.13 | 39.20 | 38.44 | 37.36 |
Diluted EPS Before Non-Recurring Items | 0.27 | 0.44 | 0.44 | 0.24 | 0.25 |
Diluted Net EPS (GAAP) | 0.27 | 0.44 | 0.44 | 0.24 | 0.25 |
Fiscal Year end for Zynex Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 47.29 | 49.92 | 44.95 | 42.17 | 48.81 |
Cost Of Goods | 10.27 | 9.55 | 9.27 | 9.27 | 9.39 |
Gross Profit | 37.01 | 40.36 | 35.68 | 32.90 | 39.42 |
SG&A, R&D, and Dept/Amort Expenses | 34.72 | 34.88 | 32.97 | 32.62 | 29.31 |
Income After SG&A, R&D, and Dept/Amort Expenses | 2.29 | 5.48 | 2.71 | 0.28 | 10.11 |
Non-Operating Income | 0.00 | -0.21 | 1.70 | 1.40 | -0.30 |
Interest Expense | 0.37 | 0.33 | 0.32 | 0.08 | 0.09 |
Pretax Income | 1.93 | 4.95 | 4.10 | 1.60 | 9.71 |
Income Taxes | 0.72 | 1.36 | 0.74 | 0.03 | 2.26 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1.22 | 3.59 | 3.35 | 1.57 | 7.45 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1.22 | 3.59 | 3.35 | 1.57 | 7.45 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 34.01 | 36.10 | 37.06 | 37.44 | 37.96 |
Diluted EPS Before Non-Recurring Items | 0.04 | 0.10 | 0.09 | 0.04 | 0.20 |
Diluted Net EPS (GAAP) | 0.04 | 0.10 | 0.09 | 0.04 | 0.20 |